NASDAQ: DXCMDEXCOM INC Stock
$77.67+2.46 (+3.27%)
Updated Jun 24, 2022
DXCM Price
$77.67
Fair Value Price
$78.13
Market Cap
$30.49B
52 Week Low
$66.89
52 Week High
$164.86
P/E
142.51x
P/B
13.92x
P/S
19.33x
PEG
3.49x
Dividend Yield
N/A
Revenue
$2.57B
Earnings
$211.70M
Gross Margin
67.4%
Operating Margin
10.59%
Profit Margin
8.2%
Debt to Equity
1.31
Operating Cash Flow
$486M
Beta
1.02
Next Earnings
Jul 27, 2022
Ex-Dividend
N/A
Next Dividend
N/A
DXCM Overview
Zen Score
–
Industry Average (34)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how DXCM scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
DXCM ($77.67) is undervalued by 0.59% relative to our estimate of its Fair Value price of $78.13 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
DXCM ($77.67) is not significantly undervalued (0.59%) relative to our estimate of its Fair Value price of $78.13 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
DXCM ($77.67) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more DXCM due diligence checks available for Premium users.
DXCM News
Valuation
DXCM fair value
Fair Value of DXCM stock based on Discounted Cash Flow (DCF)
Price
$77.67
Fair Value
$78.13
Undervalued by
0.59%
DXCM ($77.67) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
DXCM ($77.67) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
DXCM ($77.67) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
DXCM price to earnings (PE)
For valuing profitable companies with steady earnings
Company
142.51x
Industry
31.07x
Market
20.48x
DXCM is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
DXCM is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
DXCM price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
13.92x
Industry
4.09x
DXCM is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
DXCM price to earnings growth (PEG)
For valuing profitable companies with growth potential
DXCM is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
DXCM's financial health
Profit margin
Revenue
$628.8M
Net Income
$97.3M
Profit Margin
15.5%
DXCM's Earnings (EBIT) of $272.40M... subscribe to Premium to read more.
Interest Coverage Financials
DXCM's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$5.1B
Liabilities
$2.9B
Debt to equity
1.31
DXCM's short-term assets ($3.75B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
DXCM's short-term assets ($3.75B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
DXCM's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
DXCM's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$71.0M
Investing
-$411.8M
Financing
$5.3M
DXCM's operating cash flow ($485.70M)... subscribe to Premium to read more.
Debt Coverage Financials
DXCM vs Diagnostics & Research Stocks
DEXCOM Stock FAQ
©2022 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.